Elizabeth M. Gore, MD

Publications

• Optimized cardiac functional MRI of small-animal models of cancer radiation therapy.

  (Ibrahim EH, Baruah D, Budde M, Rubenstein J, Frei A, Schlaak R, Gore E, Bergom C.) Magn Reson Imaging. 2020 11;73:130-137 PMID: 32866598 PMCID: PMC7530081 SCOPUS ID: 2-s2.0-85090239163 09/01/2020

• Modeling the Impact of Cardiopulmonary Irradiation on Overall Survival in NRG Oncology Trial RTOG 0617.

  (Thor M, Deasy JO, Hu C, Gore E, Bar-Ad V, Robinson C, Wheatley M, Oh JH, Bogart J, Garces YI, Kavadi VS, Narayan S, Iyengar P, Witt JS, Welsh JW, Koprowski CD, Larner JM, Xiao Y, Bradley J.) Clin Cancer Res. 2020 Sep 01;26(17):4643-4650 PMID: 32398326 05/14/2020

• Practice Recommendations for Lung Cancer Radiotherapy During the COVID-19 Pandemic: An ESTRO-ASTRO Consensus Statement.

  (Guckenberger M, Belka C, Bezjak A, Bradley J, Daly ME, DeRuysscher D, Dziadziuszko R, Faivre-Finn C, Flentje M, Gore E, Higgins KA, Iyengar P, Kavanagh BD, Kumar S, Le Pechoux C, Lievens Y, Lindberg K, McDonald F, Ramella S, Rengan R, Ricardi U, Rimner A, Rodrigues GB, Schild SE, Senan S, Simone CB 2nd, Slotman BJ, Stuschke M, Videtic G, Widder J, Yom SS, Palma D.) Int J Radiat Oncol Biol Phys. 2020 07 15;107(4):631-640 PMID: 32589990 SCOPUS ID: 2-s2.0-85086713288 06/27/2020

• Radiation Therapy for Small Cell Lung Cancer: An ASTRO Clinical Practice Guideline.

  (Simone CB 2nd, Bogart JA, Cabrera AR, Daly ME, DeNunzio NJ, Detterbeck F, Faivre-Finn C, Gatschet N, Gore E, Jabbour SK, Kruser TJ, Schneider BJ, Slotman B, Turrisi A, Wu AJ, Zeng J, Rosenzweig KE.) Pract Radiat Oncol. 2020 May - Jun;10(3):158-173 PMID: 32222430 SCOPUS ID: 2-s2.0-85083007497 03/31/2020

• Practice recommendations for lung cancer radiotherapy during the COVID-19 pandemic: An ESTRO-ASTRO consensus statement.

  (Guckenberger M, Belka C, Bezjak A, Bradley J, Daly ME, DeRuysscher D, Dziadziuszko R, Faivre-Finn C, Flentje M, Gore E, Higgins KA, Iyengar P, Kavanagh BD, Kumar S, Le Pechoux C, Lievens Y, Lindberg K, McDonald F, Ramella S, Rengan R, Ricardi U, Rimner A, Rodrigues GB, Schild SE, Senan S, Simone CB 2nd, Slotman BJ, Stuschke M, Videtic G, Widder J, Yom SS, Palma D.) Radiother Oncol. 2020 05;146:223-229 PMID: 32342863 PMCID: PMC7252074 SCOPUS ID: 2-s2.0-85083900337 04/29/2020

• Practice Recommendations for Lung Cancer Radiotherapy During the COVID-19 Pandemic: An ESTRO-ASTRO Consensus Statement

  (Guckenberger M, Belka C, Bezjak A, Bradley J, Daly ME, DeRuysscher D, Dziadziuszko R, Faivre-Finn C, Flentje M, Gore E, Higgins KA, Iyengar P, Kavanagh BD, Kumar S, Le Pechoux C, Lievens Y, Lindberg K, McDonald F, Ramella S, Rengan R, Ricardi U, Rimner A, Rodrigues GB, Schild SE, Senan S, Simone CB, Slotman BJ, Stuschke M, Videtic G, Widder J, Yom SS, Palma D.) International Journal of Radiation Oncology Biology Physics. 15 July 2020;107(4):631-640 SCOPUS ID: 2-s2.0-85086713288 07/15/2020

• Practice recommendations for lung cancer radiotherapy during the COVID-19 pandemic: An ESTRO-ASTRO consensus statement

  (Guckenberger M, Belka C, Bezjak A, Bradley J, Daly ME, DeRuysscher D, Dziadziuszko R, Faivre-Finn C, Flentje M, Gore E, Higgins KA, Iyengar P, Kavanagh BD, Kumar S, Le Pechoux C, Lievens Y, Lindberg K, McDonald F, Ramella S, Rengan R, Ricardi U, Rimner A, Rodrigues GB, Schild SE, Senan S, Simone CB, Slotman BJ, Stuschke M, Videtic G, Widder J, Yom SS, Palma D.) Radiotherapy and Oncology. 2020 SCOPUS ID: 2-s2.0-85083900337 01/01/2020

• Changing functional status within 6 months posttreatment is prognostic of overall survival in patients with head and neck cancer: NRG Oncology Study.

  (Eldridge RC, Pugh SL, Trotti A, Hu K, Spencer S, Yom SS, Rosenthal D, Read N, Desai A, Gore E, Shenouda G, Mishra MV, Bruner D, Xiao C.) Head Neck. 2019 11;41(11):3924-3932 PMID: 31435980 PMCID: PMC6865821 SCOPUS ID: 2-s2.0-85071015198 08/23/2019

• Dosimetric Predictors of Cardiotoxicity in Thoracic Radiotherapy for Lung Cancer.

  (Borkenhagen JF, Bergom C, Rapp CT, Klawikowski SJ, Rein LE, Gore EM.) Clin Lung Cancer. 2019 11;20(6):435-441 PMID: 31303452 SCOPUS ID: 2-s2.0-85068540623 07/16/2019

• Tolerance doses for late adverse events after hypofractionated radiotherapy for prostate cancer on trial NRG Oncology/RTOG 0415.

  (Thor M, Deasy JO, Paulus R, Robert Lee W, Amin MB, Bruner DW, Low DA, Shah AB, Malone SC, Michalski JM, Dayes IS, Seaward SA, Gore EM, Albert M, Pisansky TM, Faria SL, Chen Y, Koontz BF, Swanson GP, Pugh SL, Sandler HM.) Radiother Oncol. 2019 06;135:19-24 PMID: 31015166 PMCID: PMC6582638 SCOPUS ID: 2-s2.0-85062352777 04/25/2019

• Prophylactic Cranial Irradiation vs Observation in Patients With Locally Advanced Non-Small Cell Lung Cancer: A Long-term Update of the NRG Oncology/RTOG 0214 Phase 3 Randomized Clinical Trial.

  (Sun A, Hu C, Wong SJ, Gore E, Videtic G, Dutta S, Suntharalingam M, Chen Y, Gaspar LE, Choy H.) JAMA Oncol. 2019 Jun 01;5(6):847-855 PMID: 30869743 PMCID: PMC6459052 SCOPUS ID: 2-s2.0-85062993057 03/15/2019

• Changing functional status within 6 months posttreatment is prognostic of overall survival in patients with head and neck cancer: NRG Oncology Study

  (Eldridge RC, Pugh SL, Trotti A, Hu K, Spencer S, Yom S, Rosenthal D, Read N, Desai A, Gore E, Shenouda G, Mishra MV, Bruner D, Xiao C.) Head and Neck. 2019 SCOPUS ID: 2-s2.0-85071015198 01/01/2019